Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Intas Pharma

- PMLiVE

Publicis Groupe to acquire Sapient for $3.7bn

Merger comes just months after Publicis’ failed acquisition of Omnicom

Teva Pharma logo

Cuts help Teva raise profits, despite flat sales

Earnings attributed largely to firm’s generics business

- PMLiVE

Valeant dangles higher bid in front of Allergan shareholders

Proposes $200 a share deal

The pharma business environment in the US

Tighter regulations, more pricing controls and increased international competition will drive market improvements

- PMLiVE

AbbVie board recommends dropping Shire deal

Tells stakeholders to vote against merger in light of new rules on corporate tax

- PMLiVE

AbbVie rethinks Shire merger in light of US tax crackdown

Follows action to discourage 'inversion deals' aimed at reducing corporate tax rates

Pharma deals during September 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for September 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Endo to acquire Auxilium for $2.6bn

Puts end to takeover deal for QLT

- PMLiVE

Actavis buys infectious disease specialist Durata

Will acquire US-approved Dalvance as part of the deal

Teva Pharma logo

Teva scales back R&D as Copaxone competition looms

Copaxone accounts for almost 40% of its revenue

- PMLiVE

The M&A trend in pharma

Are pharma deals back in fashion or is big pharma in retreat and needing to reshape

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links